ExploreWatchlistsPricing
  1. JP-listed companies
  2. SUZUKEN CO.,LTD.
  3. Financials
  4. Cost of revenue

SUZUKEN CO.,LTD. (9987)

Market cap
¥428.4B
P/E ratio
13x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 20252,207,720+0.29%
Mar 31, 20242,201,244+3.10%
Mar 31, 20232,135,133+3.06%
Mar 31, 20222,071,780+5.13%
Mar 31, 20211,970,637-2.42%
Mar 31, 20202,019,408+3.93%
Mar 31, 20191,943,050+0.34%
Mar 31, 20181,936,504+0.14%
Mar 31, 20171,933,851-4.54%
Mar 31, 20162,025,741+13.17%
Mar 31, 20151,790,052

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat